Venlafaxine Hydrochloride 37.5 mg/1 (Venlafaxine Hydrochloride TABLET, EXTENDED RELEASE) 37.5 mg/1

Venlafaxine Hydrochloride 37.5 mg is an extended-release tablet used for managing mood disorders and anxiety. This medication is designed to provide gradual relief and is available in a 30-tablet bottle.

Strength

37.5 mg/1

Pack Size

30 TABLET, EXTENDED RELEASE in 1 BOTTLE (13811-712-30)

Manufacturer / TM Owner

Trigen Laboratories, LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Venlafaxine Hydrochloride is commonly used to treat depression and anxiety disorders. It works by affecting the balance of natural substances in the brain, helping to improve mood and reduce anxiety. This medication is often prescribed for long-term management of these conditions.

Side Effects

Common effects of Venlafaxine Hydrochloride may include nausea, dizziness, and dry mouth. Some users also report changes in appetite or sleep patterns. These effects are typically mild and may diminish as the body adjusts to the medication.

Precautions & Warnings

Venlafaxine Hydrochloride should be handled with care, especially if you have a history of seizures or bipolar disorder. It is important to follow the prescribed dosage and consult a healthcare provider before making any changes. Keep the medication out of reach of children and pets.

Avoid Interactions

Venlafaxine Hydrochloride may interact with other medications, including those that affect serotonin levels. Alcohol and certain over-the-counter drugs can also influence its effectiveness. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

Venlafaxine Hydrochloride is used to treat depression and anxiety disorders by balancing natural substances in the brain.

Venlafaxine Hydrochloride 37.5 mg is an extended-release tablet taken orally, typically once daily. Follow your healthcare provider's instructions for the best results.

Common side effects include nausea, dizziness, dry mouth, and changes in appetite or sleep patterns.

It is generally advised to avoid alcohol while taking Venlafaxine Hydrochloride, as it may increase the risk of side effects.

Venlafaxine Hydrochloride is often prescribed for long-term use, but it should be monitored by a healthcare provider to ensure safety and effectiveness.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.